InvestorsHub Logo
Followers 1
Posts 123
Boards Moderated 0
Alias Born 03/15/2019

Re: None

Tuesday, 06/25/2019 8:54:51 AM

Tuesday, June 25, 2019 8:54:51 AM

Post# of 466031
"today announced that the first patient, who completed the Phase 2 clinical trial ANAVEX®2-73-RS-001 voluntarily moved into the extension study and was dosed in the extension study for the treatment of Rett syndrome."

I think that she should be the first patient dosed on 18th March?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News